Mark Hazeltine
About Mark Hazeltine
Mark Hazeltine serves as the Chief Financial Officer at SOLVD Health, having previously held various leadership roles at Exagen Inc. His extensive experience in finance and operations spans over two decades, with significant contributions to strategic partnerships and product portfolio expansion.
Work at Solvd Health
Mark Hazeltine currently serves as the Chief Financial Officer at SOLVD Health. He has held this position since 2024, contributing to the financial strategy and operations of the organization. His role involves overseeing financial planning, analysis, and reporting, ensuring the company's financial health and sustainability. Based in San Diego, California, Hazeltine is part of a team focused on enhancing healthcare solutions through innovative financial practices.
Previous Roles at Exagen Inc.
Mark Hazeltine has extensive experience at Exagen Inc., where he held multiple senior positions. He served as Chief Operating Officer from 2021 to 2022, General Manager from 2020 to 2021, and Chief Business Officer from 2022 to 2023. His tenure included roles such as Vice President of Finance and Senior Vice President of Finance & Corporate Development, where he played a key role in securing strategic partnerships and expanding the company's product portfolio.
Career Background in Finance
Hazeltine's career in finance began at Qualcomm, where he worked as a Materials Manager from 1996 to 2003. He then transitioned to CareFusion, serving as Director of Financial Planning & Analysis and later as Director of Financial Business Processes. His diverse experience in financial management and strategic development has equipped him with the skills necessary for leadership roles in the healthcare and technology sectors.
Educational Qualifications
Mark Hazeltine holds a Bachelor of Business Administration (BBA) from the University of San Diego. He further advanced his education by earning a Master of Business Administration (MBA) from the USC Marshall School of Business. His academic background provides a strong foundation for his extensive career in finance and business operations.
Achievements in Strategic Development
During his time at Exagen Inc., Hazeltine co-launched the company's initial public offering (IPO), facilitating its entry into the public market. He also secured several strategic partnerships that enhanced Exagen's market position and expanded its product offerings, driving growth and innovation within the company.